glp 1 neuroinflammation GLP-1 drugs calm inflammation beyond diabetes and weight loss Repurposing glucagon-like peptide-1 receptor agonists

Glutathione therapy is not recommended for certain individuals due to potential risks or interactions

It is widely used today as a key active ingredient in skincare, nutraceuticals, functional supplements, and wellness formulations

2019) and conferring therapeutic resistance to current standards of care, including chemotherapy and immunotherapy (Jeong et al

Michaloglou, W.J

Subsequently, in the large randomised placebo-controlled FIDELIO-DKD trial including adults with type 2 diabetes and CKD, finerenone reduced the risk of the primary kidney outcome (a composite of kidney failure, sustained eGFR decline 40% or kidney death) by ~20% [69]